158 related articles for article (PubMed ID: 1382002)
1. Rhabdomyosarcoma of the head and neck in children.
Coene IJ; Schouwenburg PF; Voûte PA; Marion J; Burgers V; Hilgers FJ
Clin Otolaryngol Allied Sci; 1992 Aug; 17(4):291-6. PubMed ID: 1382002
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
3. Rhabdomyosarcoma of the head and neck.
Newman AN; Rice DH
Int J Pediatr Otorhinolaryngol; 1983 Apr; 5(2):115-24. PubMed ID: 6688242
[TBL] [Abstract][Full Text] [Related]
4. [Pediatric rhabdomyosarcoma of the infratemporal fossa].
Rozan O; Janot F; Oberlin O; Schwaab G; Quintana E; Tran Ba Huy P; Georges B; Luboinski B
Ann Otolaryngol Chir Cervicofac; 2002 Sep; 119(4):195-201. PubMed ID: 12410115
[TBL] [Abstract][Full Text] [Related]
5. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O
Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454
[TBL] [Abstract][Full Text] [Related]
6. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Baker KS; Anderson JR; Link MP; Grier HE; Qualman SJ; Maurer HM; Breneman JC; Wiener ES; Crist WM
J Clin Oncol; 2000 Jun; 18(12):2427-34. PubMed ID: 10856103
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis.
Terwisscha van Scheltinga CE; Spronk P; van Rosmalen J; Wijnen MH; Heij HA; van Baren R; Merks JH; van Noesel MM; Wijnen RM
J Pediatr Surg; 2014 Mar; 49(3):416-9. PubMed ID: 24650468
[TBL] [Abstract][Full Text] [Related]
8. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
Raney RB; Meza J; Anderson JR; Fryer CJ; Donaldson SS; Breneman JC; Fitzgerald TJ; Gehan EA; Michalski JM; Ortega JA; Qualman SJ; Sandler E; Wharam MD; Wiener ES; Maurer HM; Crist WM
Med Pediatr Oncol; 2002 Jan; 38(1):22-32. PubMed ID: 11835233
[TBL] [Abstract][Full Text] [Related]
9. Rhabdomyosarcoma of the head and neck in children.
Anderson GJ; Tom LW; Womer RB; Handler SD; Wetmore RF; Potsic WP
Arch Otolaryngol Head Neck Surg; 1990 Apr; 116(4):428-31. PubMed ID: 2317324
[TBL] [Abstract][Full Text] [Related]
10. Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Chen C; Shu HK; Goldwein JW; Womer RB; Maity A
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1294-9. PubMed ID: 12654440
[TBL] [Abstract][Full Text] [Related]
11. The Intergroup Rhabdomyosarcoma Study-II.
Maurer HM; Gehan EA; Beltangady M; Crist W; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J
Cancer; 1993 Mar; 71(5):1904-22. PubMed ID: 8448756
[TBL] [Abstract][Full Text] [Related]
12. Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study.
Heyn R; Beltangady M; Hays D; Lawrence W; Newton W; Crist W; Tefft M; Maurer HM
J Clin Oncol; 1989 Feb; 7(2):200-7. PubMed ID: 2915235
[TBL] [Abstract][Full Text] [Related]
13. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyosarcoma of the head and neck in children: review and update.
Reilly BK; Kim A; Peña MT; Dong TA; Rossi C; Murnick JG; Choi SS
Int J Pediatr Otorhinolaryngol; 2015 Sep; 79(9):1477-83. PubMed ID: 26231745
[TBL] [Abstract][Full Text] [Related]
15. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.
Raney B; Anderson J; Breneman J; Donaldson SS; Huh W; Maurer H; Michalski J; Qualman S; Ullrich F; Wharam M; Meyer W;
Pediatr Blood Cancer; 2008 Jul; 51(1):17-22. PubMed ID: 18266224
[TBL] [Abstract][Full Text] [Related]
16. Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the Intergroup Rhabdomyosarcoma Study.
Raney RB; Tefft M; Newton WA; Ragab AH; Lawrence W; Gehan EA; Maurer HM
Cancer; 1987 Jan; 59(1):147-55. PubMed ID: 3791141
[TBL] [Abstract][Full Text] [Related]
17. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
[TBL] [Abstract][Full Text] [Related]
18. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716
[TBL] [Abstract][Full Text] [Related]
19. Primary chemotherapy in the treatment of children with bladder--prostate tumors in the Intergroup Rhabdomyosarcoma Study (IRS-II).
Hays DM; Raney RB; Lawrence W; Tefft M; Soule EH; Crist WM; Foulkes M; Maurer HM
J Pediatr Surg; 1982 Dec; 17(6):812-20. PubMed ID: 6761418
[TBL] [Abstract][Full Text] [Related]
20. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
